chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dose left out at 2:36PM administered at 9:00AM the next day; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose left out at 2:36PM administered at 9:00AM the next day) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose left out at 2:36PM administered at 9:00AM the next day). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose left out at 2:36PM administered at 9:00AM the next day) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product information was provided.  Treatment information was not provided.
Pt notes that her BG levels started to rise about 5 days after the vaccination and remained elevated for a little over a month later.   Her BG readings have been improved since then.  She also noted to worsening depression, fatigue, arthralgias associated beyond the initial period of the vaccination.
Patient had severe reaction to the vaccine. Injection site is red and swollen. Patient was given antibiotic, anti-inflammatory drug and prescribed hot compress by the doctor.
Information has been received from a physician concerning a 5 year old patient with no allergies or pertinent medical history who on 22-MAR-2007 was vaccinated SC with a 0.5 mL second dose of varicella virus vaccine live (Oka/Merck) (lot# "1497S"). There was no concomitant medication. On 24-Mar-2007, the patient developed 8 to 9 cm red hot and tender area at the injection site. The patient sought unspecified medical attention. No labs were performed. Subsequently, the patient recovered. No further information was provided. No product quality complaint was involved. Additional information has been requested. This is one of several reports from the same source.
Needle malfunctioned on retractable needle while giving flu shot, and the needle came off the syringe. Vaccine spilled down patient's arm. Patient had no harm, and was given a second flu vaccine.
Syncope unwittnessed with injury (laceration to head). Second episode of syncope in the presence of EMS requiring emergency care.
Patient returned to pharmacy 9-10-12 with a hard, hot-to-the-touch, red reaction at injection site. Red erythema had spread to 24" diameter across arm.
Sore and stiff arm at injection site about 3 hours after injection. 23 hours later diarrhea started and low grade fever of 99 coming and going.  The diarrhea has lasted for the last 17 hours and still occurring.  The fever is up and down as well.
then developed hives--full body hives; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 27 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 24Sep2021 18:00 (Lot number: FC3183) at the age of 27 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: BUPROPION HCL, start date: 08Sep2021. Vaccination history included: Bnt162b2 (First dose, given in the afternoon in the left arm , Lot- FC3183), administration date: 31Aug2021, when the patient was 27 years old, for COVID-19 immunization. The following information was reported: URTICARIA (non-serious) with onset 25Sep2021, outcome "recovering", described as "then developed hives--full body hives".  Additional Information: It was reported that, Caller was inquiring about side effect information for the Pfizer Covid-19 vaccine. Caller reports she received the vaccine and then developed hives-full body hives. Caller asked was this a commonly reported side effect. Caller asked as far as the hives-it's been like a week-is that common. Hives was reported as worsened. No Investigation Assessment was reported. Caller reporting on the Covid vaccine and who explains she wanted to report and ask a question. Starting about 12 hours after the vaccine she experienced full body hives and has had that every day since getting the shot; it has been about a week. Caller would like to know if this was something that was commonly reported after the second shot. Caller is a medical speech therapist. The hives are worse than when they started, they started on 25Sep2021. She started a new medication on 08Sep2021. It Bupropion HCL 75mg, Manufacturer- Heritage Pharma, No NDC, Lot, or Expiry. She was also wondering about a possible interaction with the vaccine and this product. It was reported that, Additional Vaccines Administered on Same Date of the Pfizer Suspect: none. No emergency room visit. Did a virtual visit to physician office. Prior Vaccinations (within 4 weeks), AE(s) following prior vaccinations, Patients Medical History (including any illness at time of vaccination) and relevant Tests were reported as none. Patient was not received other product.   No follow-up attempts are possible. No further information is expected.
The day after my first dose of the COVID vaccine I noticed a strange muscle twitch on the left side of my face.  It seemed to radiate from  the inside part of my cheek. It has persisted now for a year and 9 months.  It is progressively getting more severe, affecting a greater portion of the left side of my face including eyes, chin, and mouth now.
Sm developed chest pain that lasted approx one day and resolved without treatment. Approx 10 days later c/o of SOB when laying down at night.
One of five infants who experienced sterile abscess at the injection site (Deltoid) with tenderness, treatment included tylenol PRN.
1 x 2 inch erythematous, warm patch over deltoid, similar appearing patch over left upper chest. Both non-tender and no fluctuance/induration or drainage.
After vaccine, 2 hours later my eyes, lips were swollen. They said acute dehydration and my heart started pounding wildly. I went home and took Benadryl the next day I had breathing problems, 3rd day woke up with numb arm and went to ER and developed arm and left numbness and tingling that's still there today. I still have swelling in face and tongue and sores in my mouth and I have to ice myself at bedtime. and still wake up with difficulty breathing. I'm scheduled for an MRI because doctors said it's an adverse event to vaccine and I've also had hives. I will probably go back to ER because I'm having asthma issues again. I checked with my doctor about my medical records to know if I should get the vaccine and was told to get the vaccine. I have left side numbness and that's why I'm getting the MRI to rule out everything.
About 2-3 weeks after vaccination I started having ringing in both ears. This went on about one month and I reached out to my PCP and they said that there was nothing that could be done about it. Loud noises make the ringing worse and quietness helps improve it. Practicing good self care helps manage the ringing but nothing makes it go away.
Within minutes of COVID-19 injection into left arm she felt light headed and developed dry barky,  hacking relentless cough. There was no itching, hives, swelling, GI symptoms, feeling of impending  doom, throat closing, wheezing or hoarseness. She felt more difficulty on breathing out. She reports  pulse ox 98% on RA, elevated BP and normal pulse taken by paramedics.. She used her Xopenex MDI 2  puffs then repeated 2 puffs without improvement. She was already on her Breo (200/25). Paradmedics  offered her Epi after about 25 minutes and she improved within few minutes of epi injection with no  late/delayed reactions except mild headache this am. There was injection site reaction.
On 4/9, developed myalgia, headahce, stiff neck. On 4/10, he had diffuse myalgia and chills. 4/11-T 102.5, nausea, vomiting and diarrhea. 4/12-rapidly spreading erythema over the arm, fever, chills and ? like lesion at ? treated with IV Ancef. Dx vaccine ?, aseptic meningitis, lymphangitis ? Follow up: 37year old hispanic male was admitted in Apr2003 for a robust take in response to his smallpox vaccine (lyphangitis and regional adenitis) and suspected aseptic meningitis (complained of fever, chills, myalgias, stiff neck and headache; no LP completed). He was discharged after 4 days of supportive care. Upon discharge, he continued to have persistent headaches, so his deployment was deferred for 2 weeks. On 4/29/03, pt was cleared for deployment by Dr. At that time, pt reported being asymptomatic except for occasional stress related headache. In August 2003, pt reported a viral infection with respiratory symptoms, body aches, temperature of 102 and recurrence of neck pain and headaches similar to those experienced following receipt of his smallpox vaccination in April 2003. While undergoing his post deployment physical evaluation, he continues to experience headaches and neck pain and requests additional evaluation and treatment. Headaches have been persistent since August-September 2003. Describes as constant, throbbing pressure-type pain in occipital area, which radiates to his neck. Usually wakes up with headaches and pain is constant throughout the day. Rates level of pain as ranging between levels 3-5 on pain scale of 0-10. Longest period without a headache over the past 9 months has been 2 days. Unable to identify any triggering or aggravating factors. No associated symptoms such as visual changes, photosensitivity, or nausea. Reports some dizziness with position changes when getting up in the morning. Usually takes Excedrin with some relief. Has tried heat and massage to neck without improvement of pain. Pt denies any other significant changes in his health since April 2003, except he fractured his left 4th finger after an injury. He also discontinued his Nexium and had not had recurrence of his GERD symptoms.
I received the Johnson and Johnson vaccine for covid 19 on December 9, 2020 as a participant in the study program.  I am a board crtified family physician. Beginning about 12 hours after the Moderna vaccine, I became fatigued, feverish (99.1) , ached in the thighs and calves, and had a 2-3 hour salty taste triggering thirst. The injection site became very tender but there was no inflammation nor rash.   All symptoms resolved on awakening 9:00 am 1/8/21.
dizziness; headache with tingling sensation; headache with tingling sensation; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), DIZZINESS (dizziness), PARAESTHESIA (headache with tingling sensation) and HEADACHE (headache with tingling sensation) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo since February 2021. Concomitant products included DULOXETINE and GABAPENTIN for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm). On 04-Apr-2021, the patient experienced DIZZINESS (dizziness), PARAESTHESIA (headache with tingling sensation) and HEADACHE (headache with tingling sensation). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 02-Apr-2021, PAIN IN EXTREMITY (pain in arm) had resolved. At the time of the report, DIZZINESS (dizziness), PARAESTHESIA (headache with tingling sensation) and HEADACHE (headache with tingling sensation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Redness, pain, and swelling at the site of injection to left deltoid muscle, warm to the touch. Reports intermittent lower abdominal pain.
Patient received a Pfizer BioNTech Adolescent/Adult Vaccine (Lot# 301458A) that was stored in the regular freezer (-25 to  -15 oC) beyond 14 days. On 22JAN22 Pfizer responded to the Health Agency and Health Clinic that stability data does not support the use of the Pfizer Vaccine (Lot# 301458A). Pfizer further states decision to release or dispose of the product is the responsibility of Health Agency/ Health Clinic. The CDC website states that if the manufacturer does not have the information to support the stability of the vaccine, repeat the dose immediately with no minimum interval.
Client came to clinic on 01/29/2003-complaining pain in left upper arm.  Client states that after she received flu vaccine her arm hurt x1 week.  After 3 mnths the arm hurts to move up and down and backwards.  She can't disconnect bra without hurting.  No redness seen, no lung felt, no visible signs or distress.  Soreness in deltoid following flu vaccine 10/29/2002.  Copy of immunization record given to client along with Influenza VIS form.  See PMD for evaluation.  Will let clinic know outcome.  04/02/2003: Returned to clinic for some pain in left shoulder-has not improved-did not see PMD in 01/03.  No visible changes to arm-moderate to sever pain in left arm when she raises her arm or reaches toward back-pain at injection site when she does these things.  Continued pain in left arm after Influenza.  Will send a copy of this report to client.  Follow up evaluation by MD. 04/15/2003:  Client called to let nurse know she saw Dr. at left shoulder and uppoer arm pain.  He referred her to another Dr. who did x-rays and tests and determined she has bursitis of left shoulder and gave her injection in shoulder and medications.  She will return to him for follow-up.
Client experienced a syncopal episode lasting 10-15 seconds, with arms and legs convulsing twice during episode. Client then became alert & confused with rapid improvement to oriented to person, place & time.
pt recv vax 13SEP95 & 15OCt96 & pt devel what appeared to be the chickenpox lesions on arms & wrists;MD indicated pt was dx w/folliculitis which was probably caused by family's hot tub;
soreness and swelling at site of injection. Hardness, swelling approximately 3-4 inches in diameter. Redness, felt hot. Occurred approximately 8-12 hours after shot. Lasted at least 3 days. Tenderness and swelling gradually reduced over time, essentially gone by 5th or 6th day after shot. Also had itching and mild red rash at injection site approximately 2 days after injection which lasted for approx 2 days (intermittent itching).
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable other health professional. A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (vaccination age was 41-year-old), first dose intramuscularly, administered in arm left on 28Jan2021 (Batch/Lot number was not reported) as single dose and second dose intramuscularly, administered in arm left on 25Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included diabetes, HTN (hypertension) and high cholesterol. Concomitant medications received within 2 weeks of vaccination included atorvastatin; insulin; lisinopril and linagliptin (TRADJENTA), all with unknown dose, date and indication. On 06May2021, the patient was diagnosed with covid. The event resulted in doctor or other healthcare professional office/clinic visit. Lab test included rapid PCR (Nasal swab) with result was positive on 06May2021. The patient received OTC medications for the event. Prior to vaccination, was the patient was not diagnosed with COVID-19. The outcome of the event was recovering.   Information about lot/batch number has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported vaccination failure and COVID-19 cannot be ruled out.
Chills, fever, weak, diarrhea next day and today, weak, cramps, feeling poor, unable to go out
EXPIRED DOSE OF JANSSEN COVID-19 VACCINE WAS ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: 23-JUN-2021) dose was not reported, administered on 10-JUN-2021 16:33 for prophylactic vaccination. No concomitant medications were reported. On 10-JUN-2021, the subject experienced expired dose of Janssen covid-19 vaccine was administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired dose of Janssen covid-19 vaccine was administered was not reported. This report was non-serious.
Patient/significant other reported left chest pain, not radiating or shortness of breath.  No past medical history of HTN/MI/stents/CAD.  Patient moved to medical evaluation room.  EMT completed vital signs and EKG.  NP assessed cardiac, respiratory, GI, and mental health.  EKG is normal sinus with possible 1st degree AV block.  Lungs bilaterally diminished at bases.  No wheeze, no rales, no cough, and no bilateral edema.  RRR S1S2 no bruits, no gallops, no murmurs.
Rash under left arm; Swollen lymph node; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient (non-pregnant) received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, (Batch/Lot number was not reported), via an unspecified route of administration at the age of 51-year-old at arm left on 26Mar2021 09:00 at single dose for COVID-19 immunization. Medical history was not reported. The patient wasn't allergies to medications, food, or other products. Concomitant medications were none. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunisation. The patient experienced rash under left arm and swollen lymph node on 28Mar2021. The patient hasn't received any other vaccines within 4 weeks prior to the COVID vaccine. The patient hasn't received other medications within 2 weeks of vaccination. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. There was no treatment for events. The outcome of events was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
I recieved the first shot of the Gardasil series today, within 3 hours I felt very dizzy/lightheaded, it became hard to swallow, the arm that the shot was administered (left arm) became numb with a burning sensation, and my left eye felt swollen and droopy/puffy. I took benadryl, fell alseep for 2 hours, woke up and felt somewhat better. My arm still feels a little wierd though.
Covid symptoms returned and tested positive approximately 8 days after 2 st positive test; Covid symptoms returned and tested positive approximately 8 days after 2 st positive test; Interchange of vaccine products; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05May2022 as dose 4 (booster), single (Lot number: FM7553) at the age of 69 years, in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 18Feb2021 at 09:00 as dose 1, single (Lot number: 007m20a), in right arm, on 18Mar2021 at 09:00 as dose 2, single (Lot number: 002b21a), in right arm and on 16Sep2021 at 14:00 as dose 3 (booster), single (Lot number: 036c31a), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing), notes: currently taking Letrozole; "known allergies; Sulfa drugs" (unspecified if ongoing). Concomitant medication(s) included: LETROZOLE taken for breast cancer (ongoing). The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 05May2022 at 14:00, outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Covid symptoms returned and tested positive approximately 8 days after 2 st positive test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (10Oct2022) Positive, notes: Covid symptoms returned and tested positive approximately 8 days after 2 st positive test. Covid rebound . Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Vaccine received and no other medication in 2 weeks. After completing 5 days of Paxlovid, and having a week of no symptoms, Covid symptoms returned and tested positive approximately 8 days after 2st positive test. Covid rebound.  No follow-up attempts are possible. No further information is expected.
Pt experienced malaise, headache, fever, cough for 1 day post vax.
Itching; Rash all over the body; Left arm pain at the site of the injection; Feverish; Chills; Body aches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), RASH (Rash all over the body), VACCINATION SITE PAIN (Left arm pain at the site of the injection), PYREXIA (Feverish) and CHILLS (Chills) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported. No relevant concomitant medications reported.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching), RASH (Rash all over the body), VACCINATION SITE PAIN (Left arm pain at the site of the injection), PYREXIA (Feverish), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Fever chills, at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) for Fever chills, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching), RASH (Rash all over the body), VACCINATION SITE PAIN (Left arm pain at the site of the injection), PYREXIA (Feverish), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient reported (upon returning for second dose on 3/8/21) feeling a tingling sensation around her face and down her arm in the 15 minutes after vaccination the first time, it went away within 15 minutes and she had no other signs of reaction. She had the same sensation on 3/8/21 after her 2nd shot, it presented in the first 5 minutes and it was only her face that was tingling. I sat with her for the full 15 minutes and she was chatting with me the whole time with no other symptoms or signs of a reaction. By the time her 15 minute observation time was over, she said the tingling was gone.
12 hours after shot, developed 100 degree temperature, chills, headache, nausea, muscle and joint soreness, skin sensitive to touch, loss of appetite,  weakness, difficulty walking, which lasted close to 48 hours.